Clinical Trial Update: Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of RPH-104 for resolution and prevention of recurring attacks in adults with Familial Mediterranean Fe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm International, LLC | Conditions: Familial Mediterranean Fever, FMF | Phase 2 | Status: ACTIVE_NOT_RECRUITING